23 - 25 April 2023, Birmingham
![]() |
![]() |
![]() |
![]() |
EP-002 | Prostaglandin G/H Synthase Signalling promotes Poor Outcome and Chemoresistance in Acute Myeloid Leukaemia | Abdullah Alshammari | ![]() |
![]() |
|||
EP-006 | Prognostic Value of Indicators of Neoplastic Inflammation in the Patients with Acute Leukemia | Vira Barilka | ![]() |
![]() |
|||
EP-007 | A Single Centre Experience of Using Venetoclax and Azacitidine in the Treatment of AML | Emily Booth | ![]() |
![]() |
|||
EP-008 | Comparison of myeloblast cell percentage in investigations diagnosing Acute Myeloid Leukaemia | Naml Iftikhar | ![]() |
![]() |
|||
EP-009 | Induction mortality rate in eldery AML patients treated with Venetoclax/Azacitidine compared to standard induction chemotherapy. | Israa Kaddam | ![]() |
![]() |
|||
EP-010 | HUMAN PAPILLOMAVIRUS VACCINATION FOR FANCONI ANEMIA PATIENTS | eman khattab | ![]() |
![]() |
|||
EP-011 | Vyxeos for Secondary AML in the West of Scotland: A Real World Experience | James Leveson | ![]() |
![]() |
|||
EP-012 | QIP leading to a significant improvement in antibiotic outcomes in neutropenic patients with Haematological malignancies | Arina Madan | ![]() |
![]() |
|||
EP-013 | UK Healthcare Professional Experiences with Intensive Chemotherapies for AML: Survey of Tolerability and Ambulatory Delivery | Georgia Batchelor | ![]() |
![]() |
|||
EP-014 | UK Experience with Ambulatory Delivery, Hospitalisation Time and Safety of CPX-351 in Patients with AML | Georgia Batchelor | ![]() |
![]() |
|||
EP-015 | Assessing fever-to-needle times in neutropenic patients at a tertiary haemato-oncology centre | Annabelle Chung | ![]() |
![]() |
|||
PO-015 | The Journey to e-Referrals in Haematology: A Local Experience of Implementation at a Tertiary Centre | Jamila Bashir | ![]() |
![]() |
|||
EP-017 | Phase 2 Randomised Trial, Repurposing Danazol and VBaP in Low Risk Myelodysplastic Syndrome: REPAIR MDS | Manoj Raghavan | ![]() |
![]() |
|||
EP-021 | PeRsOnalised PrEhabilitation in people with acute myeloid Leukaemia; development of the PROPEL trial. | Simon Stanworth | ![]() |
![]() |
|||
PO-022 | Can Patients Meaningfully Contribute to Genomics Research? | Noemi Roy | ![]() |
![]() |
|||
EP-023 | Cytogenetic Profile of Acute Lymphoblastic Leukemia Patients and its Association with Induction Remission Status | Umarah Khan | ![]() |
![]() |
|||
EP-024 | Factors affecting the Haematopoetic stem cell engraftment in a cancer centre in South India | ARUN V J | ![]() |
![]() |
|||
EP-025 | Presenting features and long-term outcomes of paediatric patients with ALL who developed severe vincristine-induced neuropathy | Hannah Giles | ![]() |
![]() |
|||
EP-027 | A Curious Case Of Acute Lymphoblastic Leukemia With Intractable Hepatic Dysfunction: Progressive Familial Intrahepatic Cholestasis | Vagisha Sharma | ![]() |
![]() |
|||
EP-028 | Improving Laboratory Haematology Training: Developing an Educational Resource for Haematology Trainees in the West Midlands | Lorna Cain | ![]() |
![]() |
|||
EP-029 | Using Creative Methods to Enable Reflection in Haematology Teaching | Stephen Hibbs | ![]() |
![]() |
|||
EP-030 | Solving Problems and Creating Others: Five Years of Trainee-Led Educational Innovation | Stephen Hibbs | ![]() |
![]() |
|||
PO-030 | Increasing blood cancer awareness and confidence in managing patient care through online education | Khadijha Sundus | ![]() |
![]() |
|||
EP-031 | Bridging the Gap Between Patients and Clinical Trials - the End of a 3-Year Pilot | Jane Nunnick | ![]() |
![]() |
|||
EP-032 | Clinical Trials Support Service, Less Clinical Trials, More Support? | Jane Nunnick | ![]() |
![]() |
|||
EP-033 | Development of a collaborative multidisciplinary working model for a cohort of Haematology patients | Nicola Ransome | ![]() |
![]() |
|||
EP-034 | The OnControl Powered Bone Marrow: An Audit of Patient Outcomes for 79 Patients in Birmingham | Hisam Siddiqi | ![]() |
![]() |
|||
PO-034 | Ruxolitinib and Magrolimab Significantly Increases Calreticulin Expression in Myelofibrosis. Proof of Concept for Combination Therapy | Ciro Rinaldi | ![]() |
![]() |
|||
EP-035 | A Multi-modal Integrated Approach for Introducing Trainees to Blood Film Morphology | OLGA TSIAMITA | ![]() |
![]() |
|||
EP-036 | Dental pathway for patients undergoing bone marrow transplant- a service evaluation | Rakhee Budhdeo | ![]() |
![]() |
|||
EP-037 | Self-management practices in patients with a haematological malignancy: a mixed methods study. | Kirsty Crozier | ![]() |
![]() |
|||
EP-038 | Evolution of an Acute Leukaemia Nurses Group | Kirsty Crozier | ![]() |
![]() |
|||
EP-039 | Introducing an E-Game Resource to Evaluate Haemoglobinopathies Teaching in the UK and Malawi | Diana De | ![]() |
![]() |
|||
PO-039 | Evusheld Prophylaxis increases Social Interactions and improves Anxiety, Depression, Agoraphobia and Quality of Life scores in blood cancer patients | Annabel Follows | ![]() |
![]() |
|||
EP-041 | The evolution of a charity Support Services Team | Gemma Trout | ![]() |
![]() |
|||
EP-042 | Developing Nurse Researchers - Experiences from a tertiary referral centre in Wales. | Emma Williams | ![]() |
![]() |
|||
EP-043 | Ropeginterferon alfa-2b as an option in managing high-risk pregnancy in Essential Thrombocythaemia and Polycythaemia Vera | LLywelyn Cadman-Davies | ![]() |
![]() |
|||
EP-044 | The Efficacy of Rituximab in Patients with Chronic Immune Thrombocytopenic Purpura. A Single Centre Experience. | Sarah Davis | ![]() |
![]() |
|||
EP-046 | Clinical Results From Immediate Ruxolitinib to Momelotinib Transition in Patients With Myelofibrosis | Mamta Garg | ![]() |
![]() |
|||
PO-046 | United Kingdom Retrospective Observational Study of Romiplostim and Other Treatments in Early Immune Thrombocytopenia | lorraine stephens | ![]() |
![]() |
|||
PO-047 | Comparative Effectiveness of Fostamatinib vs. Rituximab in Refractory Chronic Immune Thrombocytopenia: a Network Meta-Analysis | David Gomez Ulloa | ![]() |
![]() |
|||
PO-048 | Efficacy and Safety of Erythropoiesis Stimulating Agents (ESAs) in Myelofibrosis- A Single Centre Experience. | Amany Ihab Mohamed | ![]() |
![]() |
|||
EP-048 | Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis: Results of a Long Term UK Prospective Cohort Study | Rupen Hargreaves | ![]() |
![]() |
|||
EP-049 | Pooled Long-Term Safety Data From 3 Phase 3 Randomized-Controlled Trials (RCTs) of Momelotinib (MMB) | Claire Harrison | ![]() |
![]() |
|||
EP-050 | Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients with Myelofibrosis and Thrombocytopenia | Claire Harrison | ![]() |
![]() |
|||
PO-050 | A single-centre retrospective analysis comparing the prognostic utility of the risk-stratification tools used in Myelofibrosis | Mohamed Omer | ![]() |
![]() |
|||
PO-051 | The role of Next Generation Sequencing in Myeloproliferative Neoplasms associated with Splanchnic Vein Thromboses (MPN-SVT) | Iman ORiordan | ![]() |
![]() |
|||
EP-051 | COVID-19 Pre-exposure Prophylaxis With Tixagevimab/Cilgavimab In Patients With Hematologic Malignancy: A Single Center Experience | Kee Tat Lee | ![]() |
![]() |
|||
EP-052 | Prevalence and Causes of Megaloblastic Anemia in South India | Sasmith Menakuru | ![]() |
![]() |
|||
EP-53 | Does Macrocytic Anemia Have A Correlation With The Severity Of Cirrhosis? | Menakuru Sasmith | ![]() |
![]() |
|||
PO-053 | An Audit of Paroxysmal Nocturnal Haemoglobinuria (PNH) requesting at University Hospitals of North Midlands | Jayasekara Prasangika | ![]() |
![]() |
|||
EP-054 | Aggregate Index of Systemic Inflammation and systemic inflammation response index: novel diagnostic biomarkers in Preeclampsia. | Theresa Nwagha | ![]() |
![]() |
|||
PO-055 | Thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. From UK adult ITP registry. | Vickie Mcdonald | ![]() |
![]() |
|||
EP-055 | MPN Patient Symptom Recognition: Results from the MINUTES Survey | Emma-Louise Tarburn | ![]() |
![]() |
|||
PO-056 | What Does Existing Data Tell Us About Care Experiences of Minority Ethnic Blood Cancer Patients? | Emma Caton | ![]() |
![]() |
|||
EP-056 | Lack of Correlation Between Bone Marrow Fibrosis and Efficacy of Momelotinib or Ruxolitinib in Myelofibrosis | Frances Wadelin | ![]() |
![]() |
|||
EP-057 | Management of life threatening refractory immune thrombocytopenia purpura in pregnancy and the peripartum period: | Shaista Zubair | ![]() |
![]() |
|||
EP-058 | Mycobacterium Chelonae Mimicking Erythema Nodosum Progressing to Catheter Tract Infection in a Child with Leukaemia | Ranjan Tiwari | ![]() |
![]() |
|||
PO-059 | Rates of Hospital Admission and Mortality in Patients with MGUS and COVID-19 Infection. | Ying Qi Yeo | ![]() |
![]() |
|||
EP-061 | Promoting Consultant Clinical Scientist roles in Haematology and Transfusion | Shubha Allard | ![]() |
![]() |
|||
EP-062 | Hyperhaemolysis - secondary to clostridium perfringens in a patient treated for DLBCL. | Angela Clarke | ![]() |
![]() |
|||
EP-064 | Single Unit Blood Transfusion- how are we doing? | Joanna Han Yen Ting | ![]() |
![]() |
|||
EP-065 | Evaluation of the cryotherapy effect on blast injuries by haematological indexes. | Inesa Iefimova | ![]() |
![]() |
|||
EP-066 | Donor deferral patterns among voluntary blood donors in Regional Blood Centre Batticaloa. | Gauri Jayasinghe | ![]() |
![]() |
|||
EP-067 | Characteristics of voluntary blood donors in Regional Blood Centre Batticaloa SriLanka. | Gauri Jayasinghe | ![]() |
![]() |
|||
EP-068 | Lupus anticoagulant screening: Is it done appropriately? | Ahmed Amer | ![]() |
![]() |
|||
EP-069 | A Dual Centre Retrospective Study of Prothrombin Complex Concentrate Usage | Michelle Melly | ![]() |
![]() |
|||
EP-071 | Outcome of Haematological Indices in Hospitalized Yellow Fever Patients at Federal Medical Centre, Asaba, Nigeria | Sylvia Ifeoma Obu | ![]() |
![]() |
|||
EP-072 | Analysis on the Management of Anaemia and Red cell Transfusion Thresholds in Critically ill patients | Lakeesha Piyasundara | ![]() |
![]() |
|||
EP-073 | ANAPHYLACTIC SHOCK TO A HEMATOLOGICAL DISORDER PATIENT DURING TRANSFUSION OF PLATELET-APHERESIS UNIT IN ADDITIVE SOLUTION | Bala Bhasker Poluru Mranikrinda | ![]() |
![]() |
|||
EP-074 | Recommended Cell Markers in Lymphoproliferative Diagnosis: A Delphi Poll. | Iman Qureshi | ![]() |
![]() |
|||
EP-075 | The utility of extended haematology red cell parameters for the prediction of birth outcomes. | Nicola Ransome | ![]() |
![]() |
|||
EP-079 | Prevalence of Alloimmunization among Haematology patients on chronic transfusion program attending SUH | Jimmy William | ![]() |
![]() |
|||
EP-080 | Blood tube shortages 2021: did guidance limiting usage result in reductions: a single-centre pilot audit | Lydia Wilson | ![]() |
![]() |
|||
EP-81 | Intrahepatic Cholestasis in Paediatrics Sickle Cell Disease: Two Cases from Oman | Wafa Al Sarkhi | ![]() |
![]() |
|||
EP-082 | Seroprevalence of SARS-CoV-2 in children of school-going age in District Swabi ,Pakistan | Muhammad Arif | ![]() |
![]() |
|||
EP-083 | Hypercoagulable State in Children with a-thalassemia disease and -thalassemia/haemoglobin E: Role of ROTEM and Microparticles | Chane Choed-Amphai | ![]() |
![]() |
|||
EP-084 | Therapeutic Plasma Exchange in managing Optic Neuritis in a pediatric patient. | Gauri Jayasinghe | ![]() |
![]() |
|||
EP-088 | Maintenance Rituximab in Follicular Lymphoma - A Single Centre Experience | Francis Anyanwu | ![]() |
![]() |
|||
EP-089 | Treatment Outcomes in Older Patients with Systemic Diffuse Large B-cell Lymphoma | Caragh Brien | ![]() |
![]() |
|||
PO-089 | Relationship between Skin, Blood and Lymph Node Responses in Mogamulizumab-treated Patients: MAVORIC Trial Post-hoc Analysis | Lay Ean Tan | ![]() |
![]() |
|||
EP-090 | Should age influence treatment options in elderly patients with diffuse large B-cell lymphoma? | Cameron Clark | ![]() |
![]() |
|||
EP-091 | Pathological Fracture as a Presenting Feature in Non-Hodgkins Lymphoma: A Scoping Review | Emily Davenport | ![]() |
![]() |
|||
EP-093 | Ruxolitinib in Adult Primary Hemophagocytic Lymphohistiocytosis | Betty Gration | ![]() |
![]() |
|||
EP-095 | Black pepper oil and D-Limonene inhibit growth and induce apoptosis in Mantle Cell Lymphoma | Marwa Jbara | ![]() |
![]() |
|||
EP-096 | A tertiary centre experience in using Trametinib (MEK-1 inhibitor) in multi-system Langerhans cell Histiocytosis in Scotland | Wei Lynn Khor | ![]() |
![]() |
|||
EP-098 | Is CMV Reactivation a Trouble in Non-Allogenic Transplant Cancer Patients? An Experience of Single Institute | Uzma Rasool Mahar | ![]() |
![]() |
|||
EP-099 | Two week wait referrals for patients without cancer. How much of a burden is it? | Thomas Mayo | ![]() |
![]() |
|||
EP-100 | A Retrospective Observational Study of CAR T cell therapies Outcomes- Experience from MSE Foundation Trust | Chinonye Onyeocha | ![]() |
![]() |
|||
PO-100 | Experiences of Flying in Patients With Sickle Cell Disease (SCD): A Service Evaluation Project | Thomas Glynn | ![]() |
![]() |
|||
EP-101 | Classical Hodgkin Lymphoma: Circulating Natural Killer Cell Subsets in an HIV Endemic Setting. | Jessica Opie | ![]() |
![]() |
|||
EP-102 | Modelling Acquired Resistance to Vorinostat in Sézary Syndrome Cells | Navin Kumar Verma | ![]() |
![]() |
|||
EP-103 | CD37 and ICOSLG expression in diffuse large B cell lymphoma (DLBCL). | Dominika Lubawska | ![]() |
![]() |
|||
PO-105 | Determinants of Splenic Preservation among Patients with Sickle Cell Disease in North-Eastern Nigeria | Adama Isah Ladu | ![]() |
![]() |
|||
EP-106 | Managing Severe Warm Autoimmune Haemolytic Anaemia after the SARS-Cov-2 Vaccine with Emergency Splenectomy and Eculizumab. | Emma Jackson | ![]() |
![]() |
|||
EP-107 | Clinical and Laboratory Factors Associated with Splenic Dysfunction Among Sickle Cell Disease Patients | Adama Isah Ladu | ![]() |
![]() |
|||
EP-108 | Evaluation of Red cell Inclusions for Assessing Spleen Function Among Sickle Cell Disease Patients | Adama Isah Ladu | ![]() |
![]() |
|||
PO-109 | Using wearables and web-based self-reporting to explore deep-sleep and patient-reported-outcome correlations in sickle cell disease. | Kim Summers | ![]() |
![]() |
|||
EP-109 | The Use of Fibroscans in Patients with Genetic Haemochromatosis at Diagnosis- a Single-centre Audit | Devi Purushothaman | ![]() |
![]() |
|||
EP-111 | Evaluation of serum albumin and trace elements in children with sickle cell disease | Olivier Mukuku | ![]() |
![]() |
|||
PO-111 | Mode of Nipocalimab Action and Pharmacology in Cells and Preclinical Models | Prasanthi Chengalva | ![]() |
![]() |
|||
EP-112 | Association of Platelet Integrin aIIb3 Polymorphisms with Atherosclerotic Coronary Heart Disease in Sudanese Patients | Lamyaa Ali | ![]() |
![]() |
|||
PO-112 | Designing ENERGY: A Phase 2/3 Study of Nipocalimab in Warm Autoimmune Hemolytic Anemia | Ubedul Hoda | ![]() |
![]() |
|||
EP-113 | A PNH case presenting with stent thrombosis and review of haematological presentations with stent thrombosis | Rachael Biggart | ![]() |
![]() |
|||
EP-114 | Not All Pregnancies are greeted with a Sweet Aftercourse- Thrombotic Microangiopathies in Pregnancy | Mehndi Dandwani | ![]() |
![]() |
|||
EP-115 | Management of a Thrombotic Microangiopathy Associated with EBV and CMV Infection in an ICU | El Amani Maha | ![]() |
![]() |
|||
EP-116 | Successful liquid warfarin therapy in a patient with Short Bowel Syndrome | Angela Theodoulou | ![]() |
![]() |
|||
EP-117 | High-normal renal function effect on apixaban levels for venous thromboembolism treatment in obese patients. | Raza Alikhan | ![]() |
![]() |
|||
EP-118 | Identifying Causal Variants in Young Patients with Unprovoked Thrombosis | Ammar Hilali | ![]() |
![]() |
|||
EP-119 | Summary of Use: Andexanet in Greater Glasgow and Clyde Health Board. | Laura Knox | ![]() |
![]() |
|||
EP-120 | An Audit of Heritable Thrombophilia Testing in a District General Hospital | Hui Wen Liang | ![]() |
![]() |
|||
EP-121 | QIP leading to significant improvement in DNAR-form completion for COVID-19 patients on Intensive Care | Arina Madan | ![]() |
![]() |
|||
EP-123 | A case series of Cyclophosphamide Usage in Refractory Immune Thrombotic Thrombocytopaenic Purpura (TTP). | Michelle Melly | ![]() |
![]() |
|||
EP-124 | Is there a risk of inhibitor recurrence whilst on emicizumab prophylaxis with intron 22 mutations? | Benjamin Miguras | ![]() |
![]() |
|||
EP-126 | Clinical Concordance of Radiometer AQT90 Flex Point of Care D-dimer Measurement versus Two Laboratory Methods | Bethan Phillips | ![]() |
![]() |
|||
EP-127 | Case Report of Pulmonary Embolism in a patient with Thrombotic Thrombocytopenic Purpura after Plasmapheresis | Gyuhee Seong | ![]() |
![]() |
|||
EP-128 | Integrating Psychology Services into TTP Patient Care: A Specialist Centre Experience | Rebecca J Shaw | ![]() |
![]() |
|||
EP-129 | Use of extended half-life FVIII for elective surgical procedures: a tertiary centre experience | Conor Feely | ![]() |
![]() |
|||
EP-130 | A case series of the use of Andexanet in Leeds Teaching Hospitals | Mevish Ul-haq | ![]() |
![]() |
|||
EP-132 | Incidence of Venous Thromboembolism at the Diagnosis of Diffuse Large B Cell Lymphoma | Wan Awatif Wan Mohd Zohdi | ![]() |
![]() |
|||
PO-132 | Interim results of the LEAP Pilot: Low Molecular Weight hEparin vs. Aspirin Postpartum | Evangelia Vlachodimitropoulou | ![]() |
![]() |
|||
PO-134 | Single Centre Experience on Long Term Safety and Efficacy of Emicizumab in Paediatric Patients | Eman Hassan | ![]() |
![]() |
|||
EP-134 | ROTEM and Clot Waveform Analysis as A Point-of-care Tests for Diagnosis of Disseminated Intravascular Coagulation in Critically-ill Children in Thailand | Supapitch Chanthong | ![]() |
![]() |
|||
EP-135 | Safety and Efficacy of Rivaroxaban for paediatric Cancer-AssociatedTthrombosis- Single Centre Experience | Ranjan Tiwari | ![]() |
![]() |
|||
EP-136 | Real world adverse event data for a secondary care led DOAC review process | Sarah Bond | ![]() |
![]() |
|||
EP-137 | Venous Thrombosis events associated with Thoracic Surgery in a Teaching Hospital: 2012 - 2022 | Huw Rowswell | ![]() |
![]() |
|||
EP-138 | The Effect of ABO Incompatibility on the Outcome of Stem Cell Transplant | Natasha Ali | ![]() |
![]() |
|||
PO-138 | MajesTEC-4: Phase 3 Trial of TeclistamabLenalidomide Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma | Daniel Zaldumbide | ![]() |
![]() |
|||
EP-139 | Kaposi Sarcoma Following Chimeric Antigen Receptor T-cell Therapy. | Patricia Banda | ![]() |
![]() |
|||
EP-140 | Haematologic Toxicity and Blood Product Transfusion Requirements during Autologous Stem Cell Transplant for Myeloma | Ellouise Bishop | ![]() |
![]() |
|||
EP-141 | Experiences of Patients from Minority Ethnic Backgrounds in the Stem Cell Transplant Pathway During COVID-19 | Emma Caton | ![]() |
![]() |
|||
EP-142 | Educational Requirements in the United Kingdoms CAR-T Ecosystem | Maria Garcia Gomez | ![]() |
![]() |
|||
EP-143 | Comparing Antigen Expression in Adult and Paediatric Acute Myeloid Leukaemia: a Systematic Literature Review | Hanya Ghazi | ![]() |
![]() |
|||
EP-144 | GvHD Pathological Grade Predicts Overall Survival | Edward Osmond | ![]() |
![]() |
|||
EP-145 | Haematology Ambulatory Transplant in a District General Hospital Setting Results Of Pilot Study | Debora Almeida | ![]() |
![]() |
|||
EP-146 | Empowering myeloma patients regimen control and comprehension via the use of chemotherapy compliance aids | Sandhya Abraham | ![]() |
![]() |
|||
EP-147 | Treatment Outcome of Newly Diagnosed Multiple Myeloma at the National Center of Hematology in Iraq | Abdulsalam Al-Ani | ![]() |
![]() |
|||
PO-148 | Response rates to second line treatment with Daratumumab Bortezomib Dexamethasone (DVD) in relapsed/refractory AL amyloidosis | Joshua Bomsztyk | ![]() |
![]() |
|||
EP-148 | Paraneoplastic Sarcoidosis In Multiple Myeloma . | Muzna Aquil | ![]() |
![]() |
|||
EP-149 | A Single Centre 7-year Experience of Bleeding Events In CLL Patients taking Ibrutinib and Anticoagulation | Varvara Bashkirova | ![]() |
![]() |
|||
EP-150 | Multiple myeloma revealed by sphenoid plasmacytoma | Sarra Chadli | ![]() |
![]() |
|||
EP-151 | Retrospective Review of Vaccination Status in Patients with Newly Diagnosed Chronic Lymphocytic Leukaemia | Samantha Drummond | ![]() |
![]() |
|||
EP-152 | Patient Experience in Relapsed/Refractory Chronic Lymphocytic Leukaemia UK Clinical Practice: Study Methodology Overview | Dima El Sharkawi | ![]() |
![]() |
|||
PO-153 | Monoclonal Gammopathy of Renal Significance: Are We Investigating Possible Cases Appropriately? A Quality Improvement Project. | Lisa Jeffers | ![]() |
![]() |
|||
EP-154 | Real world experience of the burden of infection in myeloma | Richard Hinton | ![]() |
![]() |
|||
PO-155 | Impact of Baseline Ocular Conditions on Belantamab Mafodotin-Related Corneal Events in Relapsed/Refractory Multiple Myeloma | Katelyn Kim | ![]() |
![]() |
|||
EP-155 | Monoclonal immunoglobulin deposition disease successfully diagnosed by laser microdissection-liquid chromatography-tandem mass spectrometry | Seiji Kakiuchi | ![]() |
![]() |
|||
EP-156 | ReVenG: A Phase 2 Study of Venetoclax plus Obinutuzumab Retreatment in Relapsed Chronic Lymphocytic Leukemia | Joanne Kelly | ![]() |
![]() |
|||
EP-157 | An audit of compliance with BCSH guidelines for investigation of M-proteins and management of MGUS. | Emily Kerr | ![]() |
![]() |
|||
PO-158 | Retrospective multi-centre study comparing survival outcomes in Chronic Lymphocytic Leukaemia (CLL) with genetic risk stratification. | Iman Qureshi | ![]() |
![]() |
|||
EP-158 | Introduction to the Role of the Myeloma Physiotherapist at Hampshire Hospitals NHS Foundation Trust (HHFT). | Emily Mean | ![]() |
![]() |
|||
PO-159 | Single-Agent Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Final Analysis of the DREAMM-2 Trial | Katelyn Kim | ![]() |
![]() |
|||
EP-159 | Outcomes from real world use of Belantamab Mafodotin at the Beatson West Of Scotland Cancer Centre (BWOSCC) in multiply relapsed/refractory myeloma patients | mairi walker | ![]() |
![]() |
|||
EP-160 | Tackling delayed Diagnosis in Myeloma: The Laboratory Best Practice Tool | Fenella Willis | ![]() |
![]() |
|||
PO-161 | Management of Cardiovascular Complications of BTKis: Are we Complying with the Good Practice Guidelines? | Nikita Sarania | ![]() |
![]() |
|||
PO-162 | Evaluating the Incidence and Outcomes of Myeloma Diagnosed via Emergency Presentations in Cardiff and Vale Health Board | Angharad Treharne-Jones | ![]() |
![]() |
|||
EP-162 | EMagine/CARTITUDE-6: DVRd Followed by Ciltacabtagene Autoleucel Versus DVRd Followed by ASCT in Newly Diagnosed Multiple Myeloma | Gordon Cook | ![]() |
![]() |
|||
PO-169 | Daratumumab Clinical Trial Analysis: Outcomes in Patients with Lenalidomide-Refractory Relapsed/Refractory Multiple Myeloma, 1-3 Prior LOT | Daniel Zaldumbude | ![]() |
![]() |
23 - 25 April 2023, Birmingham
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|